Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc A Gillinov

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
JACC. Cardiovascular Imaging|April 9, 2021
Severe Atrial Functional Mitral Regurgitation: Clinical and Echocardiographic Characteristics, Management and OutcomesOltion Mesi, Mohamed M Gad, Alejandro D Crane, et al.
JACC. Heart Failure|June 1, 2019
Sex-Based Differences in Outcomes After Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation: From the Cardiothoracic Surgical Trials NetworkGennaro Giustino, Jessica Overbey, Doris Taylor, et al.
American Heart Journal|October 23, 2021
Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA StudyJonathan P Piccini, Anders Ahlsson, Paul Dorian, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
JACC. Cardiovascular Imaging|April 9, 2021
Severe Atrial Functional Mitral Regurgitation: Clinical and Echocardiographic Characteristics, Management and OutcomesOltion Mesi, Mohamed M Gad, Alejandro D Crane, et al.
JACC. Heart Failure|June 1, 2019
Sex-Based Differences in Outcomes After Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation: From the Cardiothoracic Surgical Trials NetworkGennaro Giustino, Jessica Overbey, Doris Taylor, et al.
American Heart Journal|October 23, 2021
Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA StudyJonathan P Piccini, Anders Ahlsson, Paul Dorian, et al.
Pageof 2